Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

13th Congress of the EADO /
Essential regional control of skin cancers

3rd - 6th May 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 18.05.17
Views: 1171
Rating:

Dr Alessandro Testori - Istituto Europeo di Oncologia, Milan, Italy

Dr Testorri speaks with ecancer at EADO 2017 about preserving patient quality of life with loco-regional control of disease.

He highlights the considerations of how best relieve patients of disease burden without unnecessary damage to healthy tissue, especially when lesions and scars would be highly visible.

Dr Testorri reports successes with combining immune therapies with surgical interventions, and describes how electrochemotherapy can improve cytotoxic uptake into cancer cells.

ecancer's filming has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence